These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 23556029

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.
    Wilson S, Jones FM, Fofana HK, Landouré A, Kimani G, Mwatha JK, Sacko M, Vennervald BJ, Dunne DW.
    Parasite Immunol; 2013 Jul; 35(7-8):224-8. PubMed ID: 23521712
    [Abstract] [Full Text] [Related]

  • 3. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
    Asuming-Brempong EK, Ayi I, van der Puije W, Gyan BA, Larbi IA, Ashong Y, Frempong NA, Quartey JK, Otchere J, Jones FM, Wilson S, Dunne DW, Boakye DA.
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
    [Abstract] [Full Text] [Related]

  • 4. Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.
    Bourke CD, Nausch N, Rujeni N, Appleby LJ, Mitchell KM, Midzi N, Mduluza T, Mutapi F.
    J Infect Dis; 2013 Jul; 208(1):159-69. PubMed ID: 23045617
    [Abstract] [Full Text] [Related]

  • 5. Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment.
    Bourke CD, Nausch N, Rujeni N, Appleby LJ, Trottein F, Midzi N, Mduluza T, Mutapi F.
    PLoS Negl Trop Dis; 2014 May; 8(5):e2846. PubMed ID: 24810615
    [Abstract] [Full Text] [Related]

  • 6. Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigens.
    Wilson S, Jones FM, van Dam GJ, Corstjens PL, Riveau G, Fitzsimmons CM, Sacko M, Vennervald BJ, Dunne DW.
    J Infect Dis; 2014 Dec 15; 210(12):2009-16. PubMed ID: 25001462
    [Abstract] [Full Text] [Related]

  • 7. Human IgE response to the Schistosoma haematobium 22.6 kDa antigen.
    Fitzsimmons CM, Stewart TJ, Hoffmann KF, Grogan JL, Yazdanbakhsh M, Dunne DW.
    Parasite Immunol; 2004 Dec 15; 26(8-9):371-6. PubMed ID: 15679635
    [Abstract] [Full Text] [Related]

  • 8. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe.
    Ndhlovu P, Cadman H, Vennervald BJ, Christensen NO, Chidimu M, Chandiwana SK.
    Parasite Immunol; 1996 Apr 15; 18(4):181-91. PubMed ID: 9223173
    [Abstract] [Full Text] [Related]

  • 9. Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.
    Reimert CM, Fitzsimmons CM, Joseph S, Mwatha JK, Jones FM, Kimani G, Hoffmann KF, Booth M, Kabatereine NB, Dunne DW, Vennervald BJ.
    Clin Vaccine Immunol; 2006 May 15; 13(5):584-93. PubMed ID: 16682480
    [Abstract] [Full Text] [Related]

  • 10. Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.
    Satti MZ, Cahen P, Skov PS, Joseph S, Jones FM, Fitzsimmons C, Hoffmann KF, Reimert C, Kariuki HC, Kazibwe F, Mwatha JK, Kimani G, Vennervald BJ, Ouma JH, Kabatereine NB, Dunne DW.
    BMC Immunol; 2004 Apr 21; 5():6. PubMed ID: 15102330
    [Abstract] [Full Text] [Related]

  • 11. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
    Mitchell KM, Mutapi F, Mduluza T, Midzi N, Savill NJ, Woolhouse ME.
    PLoS Negl Trop Dis; 2014 Apr 21; 8(7):e3059. PubMed ID: 25079601
    [Abstract] [Full Text] [Related]

  • 12. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
    Zinyowera S, Muchaneta-Kubara CE, Mutapi F, Midzi N, Ndlovu PD, Mduluza T.
    Cent Afr J Med; 2006 Apr 21; 52(9-12):104-11. PubMed ID: 20353134
    [Abstract] [Full Text] [Related]

  • 13. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children.
    Naus CW, van Dam GJ, Kremsner PG, Krijger FW, Deelder AM.
    Clin Infect Dis; 1998 May 21; 26(5):1142-7. PubMed ID: 9597243
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
    Khalil HM, Abd el Baki MH, Abd el Mawla MM, Maklad KM, Sharaf SA, Saad AE.
    J Egypt Soc Parasitol; 1999 Aug 21; 29(2):395-408. PubMed ID: 10605492
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.
    Fitzsimmons CM, Joseph S, Jones FM, Reimert CM, Hoffmann KF, Kazibwe F, Kimani G, Mwatha JK, Ouma JH, Tukahebwa EM, Kariuki HC, Vennervald BJ, Kabatereine NB, Dunne DW.
    Infect Immun; 2004 Jul 21; 72(7):4023-30. PubMed ID: 15213147
    [Abstract] [Full Text] [Related]

  • 16. Antibody responses in schistosomiasis haematobium in Somalia. Relation to age and infection intensity.
    Hagi H, Huldt G, Loftenius A, Schröder H.
    Ann Trop Med Parasitol; 1990 Apr 21; 84(2):171-9. PubMed ID: 2116776
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel.
    Joseph S, Jones FM, Walter K, Fulford AJ, Kimani G, Mwatha JK, Kamau T, Kariuki HC, Kazibwe F, Tukahebwa E, Kabatereine NB, Ouma JH, Vennervald BJ, Dunne DW.
    J Infect Dis; 2004 Aug 15; 190(4):835-42. PubMed ID: 15272413
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.